Vital Therapies Raises Series C

Vital Therapies Inc. of San Diego has raised $28.1 million in Series C funding. Versant Ventures led the deal, and was joined by Delphi Ventures, HBM BioMed China, DFJ DragonFund China and return backers MedVenture Associates, Valley Ventures, Toucan Capital and Heights Capital. Vital Therapies is developing a human liver cell-based system which provides important metabolic support for patients with severe liver failure. It has raised around $40 million in total VC funding.